US FDA Clarifies: Coronavirus Vaccine Will Need Adcom Before Approval Decision
In a JAMA article, senior FDA leaders state that the outside advisers will be needed to ensure transparency given the potentially widespread use of the vaccine.
You may also be interested in...
Beyond vaccine experts, specialists in medical areas where there might be safety concerns, as well as epidemiologists, could be helpful to aid the FDA in understanding the data in a coronavirus vaccine application.
The US FDA has promised to hold a public advisory committee review before authorizing or approving any COVID-19 vaccine candidates. What could possibly go wrong?
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.